Trial · NCT04679051
Long Sleep Duration and Vascular Function
NCT04679051, Not applicable, Completed, Texas Tech University; results first posted 2023-01-12
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Long Sleep Duration and Vascular Function. Trials, record NCT04679051. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04679051
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Long Sleep Duration and Vascular Function
- NCT number
- NCT04679051
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 23 participants, actual
- Lead sponsor
- Texas Tech University
- Conditions
- Sleep
- Interventions
- Sleep duration
- First posted
- 2020-12-22
- Last updated
- 2023-01-13
- Results first posted
- 2023-01-12
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Wake in Central Aortic Pulse Pressure After 11 Hours in Bed | One night during each time in bed condition | Central aortic pulse pressure was measured one night during the week of 8 hours in bed, then again one night during the week of 11 hours in bed. Blood pressure was measured using an Oscar2 ambulatory blood pressure device. The device started recordings one hour prior to sleep and was programmed to take measurements once every 30 minutes during sleep until 10:00pm then every 45 minutes after 10:00pm until participants arose from bed. The change in central aortic pulse pressure from being awake to being asleep was compared between 8 and 11 hours in bed conditions. |
| Primary | Change in Cerebral Vascular Reactivity After 11 Hours in Bed | Morning after one week of 8 and 11 hours in bed | Blood flow measured in the middle cerebral artery during hypercapnia was measured after one week of 8 hours in bed, then again after one week of 11 hours in bed. Cerebral blood flow was measured using transcranial Doppler during 3 minutes of transient hypercapnia induced by rebreathing. Cerebral vascular reactivity was considered as the percent increase in cerebral blood flow at the end of 3 minutes of rebreathing relative to the Torr change in end-tidal carbon dioxide (percent change/Torr). |
| Primary | Change in Peak Reactive Hyperemia After 11 Hours in Bed | Morning after one week of 8 and 11 hours in bed | Peak forearm blood flow was measured after one week of 8 hours in bed, then again after one week of 11 hours in bed. Peak reactive hyperemia in the forearm (ml/100ml/min) was measured using venous occlusion plethysmography after 10 minutes of forearm ischemia resulting from blood pressure cuff inflation at the upper-arm. Peak blood flow was considered the highest blood flow measurement after the blood pressure cuff was deflated. |
| Primary | Change in Arterial Stiffness After 11 Hours in Bed | Morning after one week of 8 and 11 hours in bed | Arterial stiffness was measured after one week of 8 hours in bed, then again after one week of 11 hours in bed. Carotid-femoral pulse wave velocity was used as the measure of arterial stiffness. Radial arterial tonometry was used to derive a central aortic blood pressure wave. Wave separation analysis of the aortic pressure wave was then used to calculate pulse wave velocity from transit time and carotid-femoral path length. |
| Secondary | Change in Spatial Orientation After Aerobic Exercise | Baseline and after exercise | Score from a Manikin test of spatial orientation that participants took using a computer with automated software (Automated Neuropsychological Assessment Metrics, known as ANAM). Scores reflect "throughput scores" which is a continuous variable that is the ratio of correct answers per minute during the Manikin test. Higher throughput scores mean better outcome, in this case, better spatial orientation ability. Participants took the Manikin test after one week of 8 and 11 hours in bed (i.e., baseline) then the morning after one day of aerobic exercise. Exercise consisted of three sessions of 10 minutes brisk walking at a heart rate considered to be moderate intensity (50-70% of age-predicted maximal heart rate). Results reported reflect the change in throughput scores after exercise (morning after exercise minus baseline). |
| Secondary | Change in Executive Function After Aerobic Exercise | Baseline and after exercise | Executive function was assessed using a Stroop color-word test that participants took using a computer with automated software (Automated Neuropsychological Assessment Metrics, known as ANAM). Score reported are number of correct answers. A higher score means a better outcome, in this case, better executive functioning. Participants took the Stoop color-word test after one week of 8 and 11 hours in bed (i.e., baseline) then the morning after one day of aerobic exercise. Exercise consisted of three sessions of 10 minutes brisk walking at a heart rate considered to be moderate intensity (50-70% of age-predicted maximal heart rate). Results reported reflect the change in score after exercise (morning after exercise minus baseline). |
| Secondary | Change in Mental Flexibility After Aerobic Exercise | Baseline and after exercise | Mental flexibility was assessed using a Switching task that participants took on a computer with automated software (Automated Neuropsychological Assessment Metrics, known as ANAM). Scores reflect "throughput scores" which is a continuous variable that is the ratio of correct answers per minute during the Manikin test. Higher throughput scores mean better outcome, in this case, better mental flexibility. Participants took the Switching task after one week of 8 and 11 hours in bed (i.e., baseline) then the morning after one day of aerobic exercise. Exercise consisted of three sessions of 10 minutes brisk walking at a heart rate considered to be moderate intensity (50-70% of age-predicted maximal heart rate). Results reported reflect the change in throughput scores after exercise (morning after exercise minus baseline). |
Source ClinicalTrials.gov
Outcomes7
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Wake in Central Aortic Pulse Pressure After 11 Hours in Bed | One night during each time in bed condition | All participants who completed all study visits were included in the analysis. | mm Hg | MEAN |
| PRIMARY | Change in Cerebral Vascular Reactivity After 11 Hours in Bed | Morning after one week of 8 and 11 hours in bed | The middle cerebral artery could not be located in 3 participants, so data was analyzed in 9 participants that had complete data. | percent change/Torr | MEAN |
| PRIMARY | Change in Peak Reactive Hyperemia After 11 Hours in Bed | Morning after one week of 8 and 11 hours in bed | All participants who completed all study visits were included in the analysis. | ml/100ml/min | MEAN |
| PRIMARY | Change in Arterial Stiffness After 11 Hours in Bed | Morning after one week of 8 and 11 hours in bed | All participants who completed all study visits were included in the analysis. | m/s | MEAN |
| SECONDARY | Change in Spatial Orientation After Aerobic Exercise | Baseline and after exercise | All participants who completed all study visits were included in the analysis. | correct answers per minute | MEAN |
| SECONDARY | Change in Executive Function After Aerobic Exercise | Baseline and after exercise | All participants who completed all study visits were included in the analysis. | correct answers | MEAN |
| SECONDARY | Change in Mental Flexibility After Aerobic Exercise | Baseline and after exercise | All participants who completed all study visits were included in the analysis. | correct answers per minute | MEAN |
Source ClinicalTrials.gov
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Wake in Central Aortic Pulse Pressure After 11 Hours in Bed | 8 Hours in Bed | -1.5 | Standard Deviation 8.9 | mm Hg | |
| Change From Wake in Central Aortic Pulse Pressure After 11 Hours in Bed | 11hours in Bed | 0.5 | Standard Deviation 5.2 | mm Hg | |
| Change in Cerebral Vascular Reactivity After 11 Hours in Bed | 8 Hours in Bed | 11.9 | Standard Deviation 2.8 | percent change/Torr | |
| Change in Cerebral Vascular Reactivity After 11 Hours in Bed | 11 Hours in Bed | 11.3 | Standard Deviation 1.8 | percent change/Torr | |
| Change in Peak Reactive Hyperemia After 11 Hours in Bed | 8 Hours in Bed | 20.8 | Standard Deviation 5.8 | ml/100ml/min | |
| Change in Peak Reactive Hyperemia After 11 Hours in Bed | 11 Hours in Bed | 24.2 | Standard Deviation 7.2 | ml/100ml/min | |
| Change in Arterial Stiffness After 11 Hours in Bed | 8 Hours in Bed | 6.84 | Standard Deviation 0.64 | m/s | |
| Change in Arterial Stiffness After 11 Hours in Bed | 11 Hours in Bed | 6.96 | Standard Deviation 0.64 | m/s | |
| Change in Spatial Orientation After Aerobic Exercise | 8 Hours in Bed | 7.0 | Standard Deviation 4.7 | correct answers per minute | |
| Change in Spatial Orientation After Aerobic Exercise | 11 Hours in Bed | 3.9 | Standard Deviation 5.6 | correct answers per minute |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | 8, Then 11 Hours in Bed | 12 | |
| Overall Study | STARTED | 11, Then 8 Hours in Bed | 11 | |
| Overall Study | COMPLETED | 8, Then 11 Hours in Bed | 6 | |
| Overall Study | COMPLETED | 11, Then 8 Hours in Bed | 6 | |
| Overall Study | NOT COMPLETED | 8, Then 11 Hours in Bed | 6 | |
| Overall Study | NOT COMPLETED | 11, Then 8 Hours in Bed | 5 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | 8 Hours in Bed | 0 | 12 |
| Total, all-cause mortality | 11 Hours in Bed | 0 | 12 |
| Total, other adverse events | 8 Hours in Bed | 0 | 12 |
| Total, other adverse events | 11 Hours in Bed | 0 | 12 |
| Total, serious adverse events | 8 Hours in Bed | 0 | 12 |
| Total, serious adverse events | 11 Hours in Bed | 0 | 12 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| 8 Hours in Bed vs 11 Hours in Bed: deaths from any cause | Trial comparisons |
| 8 Hours in Bed vs 11 Hours in Bed: serious adverse events | Trial comparisons |
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04679051
GET https://conductscience.org/api/trials/v1/NCT04679051/registered